Microba Life Sciences Limited (ASX:MAP)
Australia
· Delayed Price · Currency is AUD 0.0870
+0.0030 (3.57%)
Jun 27, 2025, 3:55 PM AEST
Microba Life Sciences Market Cap
Microba Life Sciences has a market cap or net worth of 38.96 million as of June 27, 2025. Its market cap has decreased by -51.67% in one year.
Market Cap
38.96M
Enterprise Value
24.98M
Revenue
16.90M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since April 5, 2022, Microba Life Sciences's market cap has decreased from 96.03M to 38.96M, a decrease of -59.42%. That is a compound annual growth rate of -24.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 38.96M | -55.38% |
| Dec 31, 2024 | 87.33M | 8.33% |
| Dec 29, 2023 | 80.61M | -29.31% |
| Dec 30, 2022 | 114.03M | 18.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 116.20B |
| Pro Medicus | 29.31B |
| Cochlear | 19.32B |
| Sonic Healthcare | 12.66B |
| Telix Pharmaceuticals | 8.37B |
| Ramsay Health Care | 8.30B |
| Ansell | 4.40B |
| Regis Healthcare | 2.29B |